Notably, signatures of cancer-related malignancies, includingbreast and ovarian cancers, were identified as prominently associatedwith Her2-NLP treatment as compared to empty NLPs (Supporting Information Figure S4). Here, ERBB2 is linked to ovarian carcinoma.